https://www.selleckchem.com/pr....oducts/pf-07321332.h
34 mg/l) (95 % CI, -0.52, to -0.16) p less then 0.05] in participants with T2D following supplementation with resveratrol. No significant publication bias was observed in the meta-analysis. Subgroup and sensitivity analyses indicated that the pooled effects of resveratrol supplementation on CRP level in T2D patients were affected by resveratrol dose and duration of resveratrol. Random-effects meta-regression did not indicate any significant association of CRP level with potential confounders including resveratrol dose, duration of t
Like
Comment
Share
